drugset / Trial / NCT01710982
Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to evaluate the safety of TZP-101 in comparison with placebo when administered post-operatively in patients who have undergone partial bowel resection.
Timeline
- Start
- 2012-02
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ulimorelin | Small molecule | 480 ug/kg | Intravenous |